It should be emphasized that these finding are at odds with the bulk of research results, which report beneficial effects of ACE2/Ang 1-7/MasR in determining the balance between the intrarenal effects of angiotensin II and angiotensin (1-7), thus rendering this axis a target for novel therapeutic approaches in a variety of kidney disorders [33]. The gene discussed is ACE2; the disease is kidney disorder.